Explore Topics

Manufacturers

PAP 2020 panel recap: Navigating COVID-19

Strategic Global Sourcing at AmerisourceBergen

blue face masks on yellow background tiled

Manufacturers

Five growth drivers for the consumer healthcare products market

Jessica Donati

consumer scanning products on smartphone in store

Manufacturers

Biosimilars Pipeline Report: A guide for understanding the growing market

Sean McGowan

Manufacturers

Is your PIE incomplete?

September 2020

Manufacturers

Rethink field services: Three myths keeping access barriers in front of your product

Melissa Mulchahey

August 2020

Manufacturers

What a unified approach to business excellence means for patient support program success

Bill Smith

August 2020

Manufacturers

Pharma in the field: Sales reps vs. reimbursement and access specialists

Matt Sarnes, PharmD; Allen Lising

July 2020

Manufacturers

The Future of Payer Engagement: How Pharma Can Break Through

June 2020

Manufacturers

The Value of Virtual: How Remote Workshops Can Keep Market Access Efforts Moving

Bre Penzner; Nancy Young

Shanna Barnes; Myra Reinhardt

Manufacturers

Webinar Part 2: Leveraging AI within eBV to speed access to therapy

Manufacturers

Distant But Engaged: Transitioning to Virtual Training

Bryan Horveath, MS

Manufacturers

Webinar: Patient Assistance in the Wake of COVID19

Manufacturers

Simplifying the Path to Better Patient Outcomes

Tommy Bramley, PhD

Manufacturers

Commercializing in Canada: Quality Assurance and GMP Services

Innomar Strategies

April 2020

Manufacturers

Commercializing in Canada: Regulatory Publishing and Submissions

Innomar Strategies

April 2020

Manufacturers

Building Partnerships and Scaling Services to Patient Needs

Shanna Barnes

April 2020

Manufacturers

A Patient-Centric Approach to Technology and Analytics

Myra Reinhardt

Carolina Blood and Cancer Care

March 2020

Manufacturers

Physician Q&A: How to Boost Confidence in Biosimilars

Kashyap Patel, MD

February 2020

Manufacturers

Video: Removing Barriers for Biosimilars

February 2020

Manufacturers

Mind the (Evidence) Gap

Kim McLeod, MPH

February 2020

Manufacturers

Nurse Stories: Jessica

January 2020

Manufacturers

Case Study: Real-World Benefits of an Oncology Navigation Program

January 2020

Manufacturers

White Paper: Beyond the Promise of Artificial Intelligence in Electronic Benefit Verification

January 2020

The future of eBV is here. How manufacturers can use AI to help patients start life-changing therapies faster than ever.

Manufacturers

Infographic: Physician Perspectives on Biosimilars

December 2019

Manufacturers

InnomarLive 2019: Commercializing in Canada

Innomar Strategies

December 2019

E-book: Delivering Innovation, Improving Lives

December 2019

Manufacturers

Nurse Stories: Amy

November 2019

How do nurses make a difference when it comes to patient-centric adherence programs? A Lash Group nurse shares how she offers personal support for rare disease patients.

Manufacturers

How to Launch a Patient Support Program

Todd Wells

November 2019

Executive Q&A: best practices for a patient support program launch.

Manufacturers

How Patient Support Program Nurses Help Break Down Adherence Barriers

Sean McGowan; Rick Lozano

November 2019

Lash Group's nurse educators offer empathy, experience and expertise to help patients navigate the complexities of today's specialty therapies. Learn how they add critical value to adherence programs.

Manufacturers

Biosimilars: Market Insights and Growth Factors

September 2019

The growth of biosimilars presents a significant opportunity to reduce the cost of care and provide patients with greater access to affordable treatments. Our experts assess the current state and future of the biosimilars market.

Manufacturers

Biosimilars: Launch Insights From the Field

Melissa Mulchahey

September 2019

How are biosimilar manufacturers approaching patients, providers and payers? What can they do to differentiate? Xcenda shares insight from our field programs.

Manufacturers

Biosimilars: Shaping a Moving Market

September 2019

An animated, immersive biosimilar market snapshot with actionable insight for manufacturers.

Manufacturers

Case Study: Improving Speed to Therapy With Provider Portals

August 2019

Innovative therapies make innovative patient services essential. Learn how Lash Group helped one manufacturer improve speed and access to therapy with an electronic provider portal for benefit verification and prior authorization.

Manufacturers

Uncommon Commonalities: A Patient-Centric Strategy for Improving Medication Adherence

Dale Hanna

August 2019

What are the elements of innovative, effective medication adherence programs -- and how do they address the underlying causes of non-adherence?

Manufacturers

How Digital Innovation Drives Improved Market Access Strategies

July 2019

In this digital age, how can pharmaceutical manufacturers leverage innovative tools to prove their product's value proposition and overcome market access challenges?

Manufacturers

How Tech-Enabled Solutions Impact Adherence

Tommy Bramley, PhD

May 2019

Executive Q&A: The market trends and technology solutions impacting medication adherence today.

Manufacturers

Managing the Growing Expansion of Copay Accumulators

Corey Ford, MHA

March 2019

Health Systems

Our Most-Read Insights of 2018

December 2018

A collection of AmerisourceBergen's top insights from 2018, including commercialization considerations for novel therapies, emerging trends in retail and specialty pharmacy and best practices for managing inventory in the specialty practice.

Manufacturers

The Role of Foreign Trade Zones in Pharmaceutical Manufacturing Success: Part Two

Ann Pham

September 2018

How can FTZs help with commercialization success? What should manufacturers consider when evaluating a FTZ and 3PL partner?

Manufacturers

The Role of Foreign Trade Zones in Pharmaceutical Manufacturing Success: Part One

Ann Pham

September 2018

What are FTZs and why should pharma use them?

Manufacturers

The Supply Chain Redefined: Cell and Gene Therapies

July 2018

Much of the complexity of the cell and gene supply chain comes from how dependent the commercialization phase is on the clinical phase. What does integration look like, and how can the right logistics partner help?

Manufacturers

Financial Management for Cell and Gene Therapies

Albert Cooksey

July 2018

How third-party logistics (3PL) solutions can help cell and gene therapy manufacturers manage the financial aspects of launching new therapies.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part Two

Ana Stojanovska

June 2018

An executive Q&A on the role of data and the future of innovative reimbursement modeling for cell and gene therapies.

Manufacturers

How to Navigate Cell and Gene Therapy Reimbursement: Part One

Ana Stojanovska

June 2018

An executive Q&A on challenges and opportunities related to reimbursement, coding and coverage for cell and gene therapies.

Manufacturers

Rethink: Channel Strategy for Oral Oncolytics

May 2018

How manufacturers can benefit from provider-led care coordination to improve patient outcomes.

Manufacturers

How Product Commercialization Impacts Patients

May 2018

How do channel strategy decisions impact providers and patients—and how can you ensure a patient-centric commercialization strategy? Our strategic global sourcing experts share insights on how customers respond to channel strategy decisions.

Infographic: The Road to Commercialization in Canada

May 2018

Manufacturers

A New Approach to Channel Strategy for Oncology Therapies

How is manufacturer thinking around channel strategy changing for oral oncolytics?

Manufacturers

Full-line vs. Specialty Distribution

What manufacturers need to know about how distribution impacts access.

Manufacturers

Rethink: Payer Strategies for Commercializing Cell and Gene Therapies

Rethink: Payer Strategies for Commercializing Cell and Gene Therapies

Manufacturers

Seeing the Value and Transparency of Medicare Part B

Jennifer Snow, MPH

Manufacturers

Distribution Decisions

February 2018

How do manufacturers' distribution decisions ultimately impact patients? What long- and short-term disruption do direct models present? AmerisourceBergen experts offer perspective on the unintended consequences of channel strategy decisions.

Manufacturers

Leadership in Specialty

February 2018

Our strategic global sourcing experts share how AmerisourceBergen's leadership in specialty distribution influences the way we partner with manufacturers.

Manufacturers

An Inside Look at the Customer Experience

Our experts share what customers wish manufacturers knew about product access.

Manufacturers

Rethinking Reimbursement and Patient Support Following Medical Innovation

How can manufacturers approach reimbursement and patient support for cell and gene therapies and other medical innovations?

Manufacturers

The Downstream Impact of Channel Strategy Decisions

What manufacturers need to know about the customer experience.

Manufacturers

Information Exchange With Payers and Providers

What information do payers and providers want from pharma?

Manufacturers

Four Questions That Will Move Pharma Forward

December 2017

Key themes from ThinkLive 2017, AmerisourceBergen's annual manufacturer summit.

Manufacturers

How Wholesalers Have Evolved in Recent Years

November 2017

How pharmaceutical wholesalers have evolved in recent years.

Manufacturers

The Growth of Biosimilars in the Oncology Pipeline

Dave Picard; Brian Ansay

September 2017

What should biosimilar manufacturers focus on for commercialization success?

Manufacturers

Rethink: The Future of Benefit Verification

September 2017

What does the future of benefit verification look like for manufacturer patient support programs?

Manufacturers

Success Factors for Commercializing Biosimilars

Dave Picard

September 2017

Three factors that could influence biosimilars' commercial success.

Manufacturers

How to Get the Most From Outsourced Service Providers

Shanna Barnes

August 2017

Four things to keep in mind for patient support partnerships.

Manufacturers

Logistics Decisions Will Impact the Success of New Cell and Gene Therapies

Pete Belden

ICS

July 2017

In supply chain decisions, a wholly new type of product demands a wholly new definition for supply chain expertise and effective support.

Manufacturers

Commercializing Cell and Gene Therapies

July 2017

Learn what it takes to design an effective commercialization strategy and execute an integrated solution when the patient is in the supply chain.

Manufacturers

Changing Channels

Donna Gilbert

April 2017

Learn the unintended consequences of channel strategy decisions and the impact on patients and providers.

Manufacturers

Designing Patient-centric Support Programs

February 2017

Explore what it means to put patients at the center of support program design through this interactive experience drawing perspective from real patients and how they view healthcare.

Manufacturers

Orphan Drugs: Five Ways to Prove Product Value

February 2017

Demonstrate the value of rare disease therapies with these five key ways to connect where patients, physicians and payers perceive the most value.

Manufacturers

Five Oncology Trends Impacting the Patient Experience

September 2016

New challenges to oncology product access, optimized clinical outcomes and commercial success, with strategic recommendations for how pharmaceutical manufacturers can support prescribers and patients through the continuum of cancer care.

Manufacturers

Patient-Centric Product Commercialization: Part Three

July 2016

Designing support programs that are truly patient-centric and overcoming obstacles along the way.

Manufacturers

Patient-Centric Product Commercialization: Part Two

June 2016

Mapping the patient journey and building support programs that address the three biggest hurdles patients face.

Manufacturers

Patient-Centric Product Commercialization: Part One

June 2016

How can manufacturers turn patient-centricity from buzzword into reality?

Manufacturers

The Fundamentals of Commercialization Strategy

February 2015

Successful commercialization demands that manufacturers address three critical areas of opportunity — evidence, access and adherence.

Manufacturers

The Globalization of Pharma